Combination strategies are also being tested: given the network redundancy in GBM, using two aptamers to concurrently block, say, EGFRvIII and PDGFRβ has been suggested to prevent compensatory pathway activating.37 The gene discussed is PDGFRB; the disease is glioblastoma.